PALO ALTO, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific has developed its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a partnership with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox’s cloud-based AI platform, Franklin, with the introduction of the CytoScan Automated Interpretation and Reporting (AIR) solution, which simplifies cytogenetic research data analysis.
With automated interpretation and reporting, ChAS with Franklin provides an accurate and flexible workflow for rapid access to consistent, reproducible cytogenetic analysis results. While manual translation can take hours, ChaS users can now get accurate results in seconds.
“We developed the ChAS software with input from leading cytogeneticists and continue to work with our customers to make data simpler and more accurate,” said Chad Carter, vice president and general manager, micro genetics solutions, Thermo Fisher Scientific. “By partnering with Genoox, we can simplify data interpretation so our customers can focus on their research.”
“We are excited to partner with Thermo Fisher Scientific, a leader in cytogenetics,” said Amir Trabelsi, CEO and founder of Genoox. “We created Franklin to advance genomic medicine by giving users access to real-world, real-time genomic data. The combination of ChaS and Franklin continues this work and we look forward to opening the platform to ChaS users. ”
Genoox leverages the power of its community to power actionable insights from the world’s largest real-time genomic database providing professionals at the point of care. Genoox’s cloud-based AI platform, Franklin, connects physicians, genetic counselors and healthcare organizations, while enabling platform users to make impactful discoveries using the most advanced genomic tools and applications. Genox is used by more than 2,100 healthcare organizations, hospitals and medical centers in 46 markets around the world. Visit our website for more information at: www.genoox.com.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is a world leader in serving science, with annual revenues of approximately $40 billion. Our mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life science research, solving complex analytical challenges, increasing productivity in laboratories, improving patient health through diagnostics or developing and implementing life-changing therapies, we are here to support them. Our global team delivers an unparalleled combination of innovation, procurement convenience and pharmaceutical services for our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.